These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25396038)

  • 1. Carbohydrate antigen delivery by water soluble copolymers as potential anti-cancer vaccines.
    Qin Q; Yin Z; Bentley P; Huang X
    Medchemcomm; 2014 Aug; 5(8):1126-1129. PubMed ID: 25396038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines.
    Hakomori S
    Adv Exp Med Biol; 2001; 491():369-402. PubMed ID: 14533809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Virus-Like Particle-Based Tumor-Associated Carbohydrate Immunogen in a Mouse Tumor Model.
    Sungsuwan S; Wu X; Huang X
    Methods Enzymol; 2017; 597():359-376. PubMed ID: 28935111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatible single-chain polymer nanoparticles loaded with an antigen mimetic as potential anticancer vaccine.
    Gracia R; Marradi M; Salerno G; Pérez-Nicado R; Pérez-San Vicente A; Dupin D; Rodriguez J; Loinaz I; Chiodo F; Nativi C
    ACS Macro Lett; 2018 Feb; 7(2):196-200. PubMed ID: 35610892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cancer therapeutic vaccine based on clustered Tn-antigen mimetics induces strong antibody-mediated protective immunity.
    Richichi B; Thomas B; Fiore M; Bosco R; Qureshi H; Nativi C; Renaudet O; BenMohamed L
    Angew Chem Int Ed Engl; 2014 Oct; 53(44):11917-20. PubMed ID: 25168881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobacco mosaic virus as a new carrier for tumor associated carbohydrate antigens.
    Yin Z; Nguyen HG; Chowdhury S; Bentley P; Bruckman MA; Miermont A; Gildersleeve JC; Wang Q; Huang X
    Bioconjug Chem; 2012 Aug; 23(8):1694-703. PubMed ID: 22812480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boosting immunity to small tumor-associated carbohydrates with bacteriophage qβ capsids.
    Yin Z; Comellas-Aragones M; Chowdhury S; Bentley P; Kaczanowska K; Benmohamed L; Gildersleeve JC; Finn MG; Huang X
    ACS Chem Biol; 2013; 8(6):1253-62. PubMed ID: 23505965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of a single-molecule L-rhamnose-containing three-component vaccine and evaluation of antigenicity in the presence of anti-L-rhamnose antibodies.
    Sarkar S; Lombardo SA; Herner DN; Talan RS; Wall KA; Sucheck SJ
    J Am Chem Soc; 2010 Dec; 132(48):17236-46. PubMed ID: 21080675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopeptide-Coated Iron Oxide Nanoparticles as Potential Glycoconjugate-Based Synthetic Anticancer Vaccines.
    Sungsuwan S; Yin Z; Huang X
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):17535-44. PubMed ID: 26200668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of carbohydrate-specific antibodies in HLA-DR transgenic mice by a synthetic glycopeptide: a potential anti cancer vaccine for human use.
    Vichier-Guerre S; Lo-Man R; BenMohamed L; Dériaud E; Kovats S; Leclerc C; Bay S
    J Pept Res; 2003 Sep; 62(3):117-24. PubMed ID: 12895273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tn antigen analogues: the synthetic way to "upgrade" an attracting tumour associated carbohydrate antigen (TACA).
    Nativi C; Papi F; Roelens S
    Chem Commun (Camb); 2019 Jul; 55(54):7729-7736. PubMed ID: 31225574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses and Immunological Evaluation of Self-Adjuvanting Clustered N-Acetyl and N-Propionyl Sialyl-Tn Combined with a T-helper Cell Epitope as Antitumor Vaccine Candidates.
    Chang TC; Manabe Y; Fujimoto Y; Ohshima S; Kametani Y; Kabayama K; Nimura Y; Lin CC; Fukase K
    Angew Chem Int Ed Engl; 2018 Jul; 57(27):8219-8224. PubMed ID: 29768704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated carbohydrate antigens: a possible avenue for cancer prevention.
    Xu Y; Sette A; Sidney J; Gendler SJ; Franco A
    Immunol Cell Biol; 2005 Aug; 83(4):440-8. PubMed ID: 16033540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure Guided Design of Bacteriophage Qβ Mutants as Next Generation Carriers for Conjugate Vaccines.
    Sungsuwan S; Wu X; Shaw V; Kavunja H; McFall-Boegeman H; Rashidijahanabad Z; Tan Z; Lang S; Tahmasebi Nick S; Lin PH; Yin Z; Ramadan S; Jin X; Huang X
    ACS Chem Biol; 2022 Nov; 17(11):3047-3058. PubMed ID: 35142488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advance in Tumor-associated Carbohydrate Antigens (TACAs)-based Antitumor Vaccines.
    Feng D; Shaikh AS; Wang F
    ACS Chem Biol; 2016 Apr; 11(4):850-63. PubMed ID: 26895482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity.
    Laubreton D; Bay S; Sedlik C; Artaud C; Ganneau C; Dériaud E; Viel S; Puaux AL; Amigorena S; Gérard C; Lo-Man R; Leclerc C
    Cancer Immunol Immunother; 2016 Mar; 65(3):315-25. PubMed ID: 26847142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model.
    Song C; Zheng XJ; Liu CC; Zhou Y; Ye XS
    Oncotarget; 2017 Jul; 8(29):47330-47343. PubMed ID: 28537884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precise immunological evaluation rationalizes the design of a self-adjuvanting vaccine composed of glycan antigen, TLR1/2 ligand, and T-helper cell epitope.
    Chang TC; Manabe Y; Ito K; Yamamoto R; Kabayama K; Ohshima S; Kametani Y; Fujimoto Y; Lin CC; Fukase K
    RSC Adv; 2022 Jun; 12(29):18985-18993. PubMed ID: 35873332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.
    Wafa EI; Geary SM; Goodman JT; Narasimhan B; Salem AK
    Acta Biomater; 2017 Mar; 50():417-427. PubMed ID: 28063991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant Impact of Immunogen Design on the Diversity of Antibodies Generated by Carbohydrate-Based Anticancer Vaccine.
    Yin Z; Chowdhury S; McKay C; Baniel C; Wright WS; Bentley P; Kaczanowska K; Gildersleeve JC; Finn MG; BenMohamed L; Huang X
    ACS Chem Biol; 2015 Oct; 10(10):2364-72. PubMed ID: 26262839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.